Tuesday, 28.02.2023
19.00 - 20.00 o'clock
19.00 - 20.00 o'clock
Tuesday, 11/15/2022
7.00 - 8.00 pm CET
7.00 - 8.00 pm CET
• Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)